InvestorsHub Logo
Followers 66
Posts 12688
Boards Moderated 0
Alias Born 06/03/2015

Re: Joseph_K post# 447282

Thursday, 01/11/2024 2:18:02 PM

Thursday, January 11, 2024 2:18:02 PM

Post# of 459849
He spent significant time comparing efficacy of blarcamesine and ease of administration versus the mabs. That was impactful, as well as the RWE of Rett patients showing QoL improvements... in mobility and reduction of seizure frequency. Excellent qualitative addition!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News